Digitisation | September 30, 2021
Wyss Center receives CE mark for Epios Cloud software
The cloud-based platform enables long-term brain monitoring towards personalized treatment
The cloud-based platform enables long-term brain monitoring towards personalized treatment
The new devices company will scale up its teams to create a world-class R&D centre for medical devices in India
This project will be conducted at the “NURA,” a health screening centre that Fujifilm opened in India in February this year
_256_384.jpg)
Terumo’s first product was the domestically produced, safe, high-quality thermometer. The company has since supported the healthcare ecosystem worldwide
Surufatinib is the third potential new medicine discovered by the company to enter into clinical development in Japan
The net proceeds from the issue will be utilised towards the purchase of machinery, modernising existing units and expansion of its R&D facilities
Takeda is establishing the capability to manufacture TAK-019 (known outside Japan as NVX-CoV2373) at its facilities in Japan and aims to begin distribution in the early calendar year 2022
As of FY21, it is the largest independent medical device company and the second-largest company overall, in the surgical consumables market in India with a 7.91 per cent share based on the value
Amptron’s R &D is based out of the US and this will enable Max to obtain US and other global certifications. Max will retain the right to market, sell and distribute the products in India.
The investment is part of the group's digital health initiatives, to foster affordable access to world-class technology and an innovation-led healthcare ecosystem in India
Subscribe To Our Newsletter & Stay Updated
